世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000039675

胃がん治療薬の世界市場(2024-2028)

TechNavio

Global gastric cancer drugs market 2024-2028

発刊日 2024/06/18

言語英語

体裁PDF/168ページ

ライセンス/価格168ページ

0000039675

Single
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

胃がん治療薬市場は、2023年から2028年の間に194億8,960万米ドル成長し、予測期間中に18.52%のCAGRで加速すると予測されています。このレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題、および約25のベンダーをカバーするベンダー分析を提供します。

このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。胃がんに対する啓発活動の強化、高齢者人口の増加、胃がん罹患率の上昇により、市場は牽引されています。

調査範囲

  • 市場セグメント
    ➣ 投与経路別
      ◇ 注射剤
      ◇ 経口薬
    ➣ 流通チャネル別
      ◇ オフライン
      ◇ オンライン
    ➣ 地域別
      ◇ 北アメリカ
      ◇ ヨーロッパ
      ◇ アジア
      ◇ その他の地域

この調査では、今後数年間の胃がん治療薬市場の成長を牽引する主な理由の1つとして、医薬品の承認数と発売数の増加が挙げられています。また、胃がん治療薬の強力なパイプラインとベンダーによる研究開発の増加により、市場でかなりの需要が生まれるでしょう。

胃がん治療薬市場に関するレポートは、次の分野をカバーしています。

  • 胃がん治療薬市場の規模
  • 胃がん治療薬市場の予測
  • 胃がん治療薬市場の業界分析

堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されています。

  • 調査企業
    ➣ Abbott Laboratories
    ➣ AbbVie Inc.
    ➣ AROG Pharmaceuticals INC.
    ➣ AstraZeneca PLC
    ➣ Bayer AG, Biocon Ltd.
    ➣ Blueprint Medicines Corp.
    ➣ Boehringer Ingelheim International GmbH
    ➣ Bristol Myers Squibb Co.
    ➣ Celltrion Co. Ltd.
    ➣ DR Reddys Laboratories Ltd.
    ➣ エーザイ(Eisai Co. Ltd.)
    ➣ Eli Lilly and Co.
    ➣ F. Hoffmann La Roche Ltd.
    ➣ Merck KGaA, Novartis A
    ➣ 大塚ホールディングス(Otsuka Holdings Co. Ltd.)
    ➣ Samsung Biologics Co. Ltd.
    ➣ 武田製薬工業(Takeda Pharmaceutical Co. Ltd.)
    ➣ Zydus Lifesciences Ltd.

また、本レポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。

この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。

このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。

レポート詳細

目次

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market by Geography
Executive Summary - Chart on Market Segmentation by Route of Administration
Executive Summary - Chart on Market Segmentation by Distribution Channel
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning

2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis

3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size
4.1 Global Gastric Cancer Drugs Market 2018 - 2022
Historic Market Size - Data Table on Global Gastric Cancer Drugs Market 2018 - 2022 ($ million)
4.2 Route of Administration segment analysis 2018 - 2022
Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
4.3 Distribution Channel segment analysis 2018 - 2022
Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
4.4 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Route of Administration
6.1 Market segments
Chart on Route of Administration - Market share 2023-2028 (%)
Data Table on Route of Administration - Market share 2023-2028 (%)
6.2 Comparison by Route of Administration
Chart on Comparison by Route of Administration
Data Table on Comparison by Route of Administration
6.3 Injectable - Market size and forecast 2023-2028
Chart on Injectable - Market size and forecast 2023-2028 ($ million)
Data Table on Injectable - Market size and forecast 2023-2028 ($ million)
Chart on Injectable - Year-over-year growth 2023-2028 (%)
Data Table on Injectable - Year-over-year growth 2023-2028 (%)
6.4 Oral - Market size and forecast 2023-2028
Chart on Oral - Market size and forecast 2023-2028 ($ million)
Data Table on Oral - Market size and forecast 2023-2028 ($ million)
Chart on Oral - Year-over-year growth 2023-2028 (%)
Data Table on Oral - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Route of Administration
Market opportunity by Route of Administration ($ million)
Data Table on Market opportunity by Route of Administration ($ million)

7 Market Segmentation by Distribution Channel
7.1 Market segments
Chart on Distribution Channel - Market share 2023-2028 (%)
Data Table on Distribution Channel - Market share 2023-2028 (%)
7.2 Comparison by Distribution Channel
Chart on Comparison by Distribution Channel
Data Table on Comparison by Distribution Channel
7.3 Offline - Market size and forecast 2023-2028
Chart on Offline - Market size and forecast 2023-2028 ($ million)
Data Table on Offline - Market size and forecast 2023-2028 ($ million)
Chart on Offline - Year-over-year growth 2023-2028 (%)
Data Table on Offline - Year-over-year growth 2023-2028 (%)
7.4 Online - Market size and forecast 2023-2028
Chart on Online - Market size and forecast 2023-2028 ($ million)
Data Table on Online - Market size and forecast 2023-2028 ($ million)
Chart on Online - Year-over-year growth 2023-2028 (%)
Data Table on Online - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Distribution Channel
Market opportunity by Distribution Channel ($ million)
Data Table on Market opportunity by Distribution Channel ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Chart on Market share by geography 2023-2028 (%)
Data Table on Market share by geography 2023-2028 (%)
9.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ million)
Data Table on UK - Market size and forecast 2023-2028 ($ million)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
9.10 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ million)
Data Table on China - Market size and forecast 2023-2028 ($ million)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
9.11 Canada - Market size and forecast 2023-2028
Chart on Canada - Market size and forecast 2023-2028 ($ million)
Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Chart on Canada - Year-over-year growth 2023-2028 (%)
Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity by geography
Market opportunity by geography ($ million)
Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Opportunity/Restraints
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints

11 Competitive Landscape
11.1 Overview
11.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
Overview on factors of disruption
11.4 Industry risks
Impact of key risks on business

12 Competitive Analysis
12.1 Companies profiled
Companies covered
12.2 Market positioning of companies
Matrix on companies position and classification
12.3 Abbott Laboratories
Abbott Laboratories - Overview
Abbott Laboratories - Business segments
Abbott Laboratories - Key news
Abbott Laboratories - Key offerings
Abbott Laboratories - Segment focus
12.4 AROG Pharmaceuticals INC.
AROG Pharmaceuticals INC. - Overview
AROG Pharmaceuticals INC. - Product / Service
AROG Pharmaceuticals INC. - Key offerings
12.5 AstraZeneca Plc
AstraZeneca Plc - Overview
AstraZeneca Plc - Product / Service
AstraZeneca Plc - Key news
AstraZeneca Plc - Key offerings
12.6 Bayer AG
Bayer AG - Overview
Bayer AG - Business segments
Bayer AG - Key news
Bayer AG - Key offerings
Bayer AG - Segment focus
12.7 Biocon Ltd.
Biocon Ltd. - Overview
Biocon Ltd. - Business segments
Biocon Ltd. - Key offerings
Biocon Ltd. - Segment focus
12.8 Boehringer Ingelheim International GmbH
Boehringer Ingelheim International GmbH - Overview
Boehringer Ingelheim International GmbH - Product / Service
Boehringer Ingelheim International GmbH - Key news
Boehringer Ingelheim International GmbH - Key offerings
12.9 Bristol Myers Squibb Co.
Bristol Myers Squibb Co. - Overview
Bristol Myers Squibb Co. - Product / Service
Bristol Myers Squibb Co. - Key news
Bristol Myers Squibb Co. - Key offerings
12.10 Celltrion Co. Ltd.
Celltrion Co. Ltd. - Overview
Celltrion Co. Ltd. - Product / Service
Celltrion Co. Ltd. - Key offerings
12.11 Dr Reddys Laboratories Ltd.
Dr Reddys Laboratories Ltd. - Overview
Dr Reddys Laboratories Ltd. - Business segments
Dr Reddys Laboratories Ltd. - Key news
Dr Reddys Laboratories Ltd. - Key offerings
Dr Reddys Laboratories Ltd. - Segment focus
12.12 Eisai Co. Ltd.
Eisai Co. Ltd. - Overview
Eisai Co. Ltd. - Business segments
Eisai Co. Ltd. - Key offerings
Eisai Co. Ltd. - Segment focus
12.13 Eli Lilly and Co.
Eli Lilly and Co. - Overview
Eli Lilly and Co. - Product / Service
Eli Lilly and Co. - Key news
Eli Lilly and Co. - Key offerings
12.14 F. Hoffmann La Roche Ltd.
F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
12.15 Merck KGaA
Merck KGaA - Overview
Merck KGaA - Business segments
Merck KGaA - Key news
Merck KGaA - Key offerings
Merck KGaA - Segment focus
12.16 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
12.17 Samsung Biologics Co. Ltd.
Samsung Biologics Co. Ltd. - Overview
Samsung Biologics Co. Ltd. - Product / Service
Samsung Biologics Co. Ltd. - Key offerings

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
13.3 Currency conversion rates for US$
Currency conversion rates for US$
13.4 Research methodology
Research methodology
13.5 Data procurement
Information sources
13.6 Data validation
Data validation
13.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
13.8 Data synthesis
Data synthesis
360 degree market analysis
360 degree market analysis
13.10 List of abbreviations
List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Company Market Positioning
Exhibits10: Parent Market
Exhibits11: Data Table on - Parent Market
Exhibits12: Market characteristics analysis
Exhibits13: Value Chain Analysis
Exhibits14: Offerings of companies included in the market definition
Exhibits15: Market segments
Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits20: Historic Market Size - Data Table on Global Gastric Cancer Drugs Market 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits25: Five forces analysis - Comparison between 2023 and 2028
Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits31: Chart on Market condition - Five forces 2023 and 2028
Exhibits32: Chart on Route of Administration - Market share 2023-2028 (%)
Exhibits33: Data Table on Route of Administration - Market share 2023-2028 (%)
Exhibits34: Chart on Comparison by Route of Administration
Exhibits35: Data Table on Comparison by Route of Administration
Exhibits36: Chart on Injectable - Market size and forecast 2023-2028 ($ million)
Exhibits37: Data Table on Injectable - Market size and forecast 2023-2028 ($ million)
Exhibits38: Chart on Injectable - Year-over-year growth 2023-2028 (%)
Exhibits39: Data Table on Injectable - Year-over-year growth 2023-2028 (%)
Exhibits40: Chart on Oral - Market size and forecast 2023-2028 ($ million)
Exhibits41: Data Table on Oral - Market size and forecast 2023-2028 ($ million)
Exhibits42: Chart on Oral - Year-over-year growth 2023-2028 (%)
Exhibits43: Data Table on Oral - Year-over-year growth 2023-2028 (%)
Exhibits44: Market opportunity by Route of Administration ($ million)
Exhibits45: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits46: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibits47: Data Table on Distribution Channel - Market share 2023-2028 (%)
Exhibits48: Chart on Comparison by Distribution Channel
Exhibits49: Data Table on Comparison by Distribution Channel
Exhibits50: Chart on Offline - Market size and forecast 2023-2028 ($ million)
Exhibits51: Data Table on Offline - Market size and forecast 2023-2028 ($ million)
Exhibits52: Chart on Offline - Year-over-year growth 2023-2028 (%)
Exhibits53: Data Table on Offline - Year-over-year growth 2023-2028 (%)
Exhibits54: Chart on Online - Market size and forecast 2023-2028 ($ million)
Exhibits55: Data Table on Online - Market size and forecast 2023-2028 ($ million)
Exhibits56: Chart on Online - Year-over-year growth 2023-2028 (%)
Exhibits57: Data Table on Online - Year-over-year growth 2023-2028 (%)
Exhibits58: Market opportunity by Distribution Channel ($ million)
Exhibits59: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits61: Chart on Market share by geography 2023-2028 (%)
Exhibits62: Data Table on Market share by geography 2023-2028 (%)
Exhibits63: Chart on Geographic comparison
Exhibits64: Data Table on Geographic comparison
Exhibits65: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits66: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits67: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits68: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits69: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits70: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits71: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits72: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits73: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits74: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits75: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits76: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits77: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits78: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits79: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits80: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits81: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits82: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits83: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits84: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits85: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits86: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits87: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits88: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits89: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits90: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits91: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits92: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits93: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits94: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits95: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits96: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits97: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits98: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits99: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits100: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits101: Market opportunity by geography ($ million)
Exhibits102: Data Tables on Market opportunity by geography ($ million)
Exhibits103: Impact of drivers and challenges in 2023 and 2028
Exhibits104: Overview on criticality of inputs and factors of differentiation
Exhibits105: Overview on factors of disruption
Exhibits106: Impact of key risks on business
Exhibits107: Companies covered
Exhibits108: Matrix on companies position and classification
Exhibits109: Abbott Laboratories - Overview
Exhibits110: Abbott Laboratories - Business segments
Exhibits111: Abbott Laboratories - Key news
Exhibits112: Abbott Laboratories - Key offerings
Exhibits113: Abbott Laboratories - Segment focus
Exhibits114: AROG Pharmaceuticals INC. - Overview
Exhibits115: AROG Pharmaceuticals INC. - Product / Service
Exhibits116: AROG Pharmaceuticals INC. - Key offerings
Exhibits117: AstraZeneca Plc - Overview
Exhibits118: AstraZeneca Plc - Product / Service
Exhibits119: AstraZeneca Plc - Key news
Exhibits120: AstraZeneca Plc - Key offerings
Exhibits121: Bayer AG - Overview
Exhibits122: Bayer AG - Business segments
Exhibits123: Bayer AG - Key news
Exhibits124: Bayer AG - Key offerings
Exhibits125: Bayer AG - Segment focus
Exhibits126: Biocon Ltd. - Overview
Exhibits127: Biocon Ltd. - Business segments
Exhibits128: Biocon Ltd. - Key offerings
Exhibits129: Biocon Ltd. - Segment focus
Exhibits130: Boehringer Ingelheim International GmbH - Overview
Exhibits131: Boehringer Ingelheim International GmbH - Product / Service
Exhibits132: Boehringer Ingelheim International GmbH - Key news
Exhibits133: Boehringer Ingelheim International GmbH - Key offerings
Exhibits134: Bristol Myers Squibb Co. - Overview
Exhibits135: Bristol Myers Squibb Co. - Product / Service
Exhibits136: Bristol Myers Squibb Co. - Key news
Exhibits137: Bristol Myers Squibb Co. - Key offerings
Exhibits138: Celltrion Co. Ltd. - Overview
Exhibits139: Celltrion Co. Ltd. - Product / Service
Exhibits140: Celltrion Co. Ltd. - Key offerings
Exhibits141: Dr Reddys Laboratories Ltd. - Overview
Exhibits142: Dr Reddys Laboratories Ltd. - Business segments
Exhibits143: Dr Reddys Laboratories Ltd. - Key news
Exhibits144: Dr Reddys Laboratories Ltd. - Key offerings
Exhibits145: Dr Reddys Laboratories Ltd. - Segment focus
Exhibits146: Eisai Co. Ltd. - Overview
Exhibits147: Eisai Co. Ltd. - Business segments
Exhibits148: Eisai Co. Ltd. - Key offerings
Exhibits149: Eisai Co. Ltd. - Segment focus
Exhibits150: Eli Lilly and Co. - Overview
Exhibits151: Eli Lilly and Co. - Product / Service
Exhibits152: Eli Lilly and Co. - Key news
Exhibits153: Eli Lilly and Co. - Key offerings
Exhibits154: F. Hoffmann La Roche Ltd. - Overview
Exhibits155: F. Hoffmann La Roche Ltd. - Business segments
Exhibits156: F. Hoffmann La Roche Ltd. - Key news
Exhibits157: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits158: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits159: Merck KGaA - Overview
Exhibits160: Merck KGaA - Business segments
Exhibits161: Merck KGaA - Key news
Exhibits162: Merck KGaA - Key offerings
Exhibits163: Merck KGaA - Segment focus
Exhibits164: Novartis AG - Overview
Exhibits165: Novartis AG - Business segments
Exhibits166: Novartis AG - Key news
Exhibits167: Novartis AG - Key offerings
Exhibits168: Novartis AG - Segment focus
Exhibits169: Samsung Biologics Co. Ltd. - Overview
Exhibits170: Samsung Biologics Co. Ltd. - Product / Service
Exhibits171: Samsung Biologics Co. Ltd. - Key offerings
Exhibits172: Inclusions checklist
Exhibits173: Exclusions checklist
Exhibits174: Currency conversion rates for US$
Exhibits175: Research methodology
Exhibits176: Information sources
Exhibits177: Data validation
Exhibits178: Validation techniques employed for market sizing
Exhibits179: Data synthesis
Exhibits180: 360 degree market analysis
Exhibits181: List of abbreviations

この商品のレポートナンバー

0000039675

TOP